Correction to: T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
Eur Radiol.
2021 Apr;31(4):2644. doi: 10.1007/s00330-020-07285-8. PubMed PMID:
32945970.
T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
Eur Radiol.
2021 Mar;31(3):1336-1346. doi: 10.1007/s00330-020-07214-9. Epub 2020 Sep 2. PubMed PMID:
32876839; PubMed Central PMCID:
PMC7882016.
A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI.
EBioMedicine.
2021 Jan;63:103163. doi: 10.1016/j.ebiom.2020.103163. Epub 2020 Dec 13. PubMed PMID:
33321450; PubMed Central PMCID:
PMC7744939.
Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.
Eur Radiol.
2021 Jan;31(1):379-391. doi: 10.1007/s00330-020-07065-4. Epub 2020 Jul 23. PubMed PMID:
32700021; PubMed Central PMCID:
PMC7821380.
Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study.
Cancers (Basel).
2020 Aug 6;12(8). doi: 10.3390/cancers12082200. PubMed PMID:
32781640; PubMed Central PMCID:
PMC7465024.
Test-retest reliability of Diffusion Tensor Imaging metrics in neonates.
Neuroimage.
2019 Aug 15;197:598-607. doi: 10.1016/j.neuroimage.2019.04.067. Epub 2019 Apr 25. PubMed PMID:
31029873.
Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
J Magn Reson Imaging.
2018 Dec;48(6):1626-1636. doi: 10.1002/jmri.26178. Epub 2018 May 7. PubMed PMID:
29734484; PubMed Central PMCID:
PMC6222024.
Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
J Magn Reson Imaging.
2018 Feb 22;. doi: 10.1002/jmri.25983. [Epub ahead of print] PubMed PMID:
29469937; PubMed Central PMCID:
PMC6105554.
Prostate shapes on pre-treatment MRI between prostate cancer patients who do and do not undergo biochemical recurrence are different: Preliminary Findings.
Sci Rep.
2017 Nov 20;7(1):15829. doi: 10.1038/s41598-017-13443-8. PubMed PMID:
29158516; PubMed Central PMCID:
PMC5696460.
Radiomics based targeted radiotherapy planning (Rad-TRaP): a computational framework for prostate cancer treatment planning with MRI.
Radiat Oncol.
2016 Nov 10;11(1):148. doi: 10.1186/s13014-016-0718-3. PubMed PMID:
27829431; PubMed Central PMCID:
PMC5103611.
What would you like to do?